New CFO For Soligenix
Late-stage biopharma company Soligenix Inc. has appointed Karen Krumeich senior vice president and chief financial officer (CFO), following the retirement of current acting CFO Joseph Warusz at the end of this month. Prior to joining Soligenix, Krumeich served as a consultant providing finance, investor relations and business development services to the company, before which she was vice president and CFO for several development-stage life science companies, including Cerecor Inc. and Mela Sciences Inc.
You may also be interested in...
The pharma, biotech and allied industries came together in London on 4 December to celebrate another year of achievement at the 15th Annual Scrip Awards, hosted by the broadcaster Fiona Bruce.
We are delighted to announce the shortlist for the 15th Annual Scrip Awards.
The financing, which brings the total raised by Juvenescence to $165m, comes as longevity R&D programs supported by the company move towards human testing.